Andre P Fay: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Andre P Fay

Dr. Andre P Fay is a Medical Oncologist and Professor of Medicine at PUCRS School of Medicine in Porto Alegre, Brazil. He is also a Visiting Scientist at Dana-Farber Cancer Institute.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Fay will present on “The Current State of Renal Oncology in Brazil.” His presentation will cover:

• The epidemiology, clinical management, and recent advances in renal cell carcinoma in Brazil.
• Consensus treatment recommendations developed by the Latin American Cooperative Oncology Group (LACOG) and Latin American Renal Cancer Group.
• The integration of immunotherapy and targeted therapies as standards of care in advanced disease.
• Challenges and opportunities in improving patient access to novel treatments across Brazil’s diverse healthcare settings.

Dr. Fay’s insights reflect both academic expertise and real-world clinical experience to advance renal oncology care in Brazil.

Global Voices in Renal Oncology (VIRO) 2025